MIM
LIVN icon

MetLife Investment Management’s LivaNova LIVN Stock Holding History

MetLife Investment Management’s Portfolio LIVN Stock Details LIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79M Buy
58,262
+1,924
+3% +$136K 0.02% 661
2026
Q1 		$3.58M Buy
56,338
+236
+0.4% +$15.2K 0.02% 766
2025
Q4 		$3.45M Sell
56,102
-3,382
-6% -$193K 0.02% 799
2025
Q3 		$3.12M Sell
59,484
-1,788
-3% -$90K 0.02% 869
2025
Q2 		$2.76M Sell
61,272
-724
-1% -$29.9K 0.02% 838
2025
Q1 		$2.44M Sell
61,996
-1,036
-2% -$46.5K 0.01% 950
2024
Q4 		$2.92M Buy
63,032
+4,413
+8% +$226K 0.02% 854
2024
Q3 		$3.08M Sell
58,619
-433
-0.7% -$21.5K 0.02% 796
2024
Q2 		$3.24M Buy
59,052
+2,462
+4% +$140K 0.02% 739
2024
Q1 		$3.17M Sell
56,590
-1,603
-3% -$83.3K 0.02% 745
2023
Q4 		$3.01M Buy
+58,193
New +$2.82M 0.02% 769
2023
Q3 		– Sell
-60,016
Closed -$3.09M – 2940
2023
Q2 		$3.09M Sell
60,016
-209
-0.3% -$9.81K 0.02% 734
2023
Q1 		$2.62M Sell
60,225
-880
-1% -$44.6K 0.02% 805
2022
Q4 		$3.39M Sell
61,105
-694
-1% -$35.4K 0.03% 670
2022
Q3 		$3.14M Sell
61,799
-342
-0.6% -$20.3K 0.03% 666
2022
Q2 		$3.88M Buy
62,141
+270
+0.4% +$19.1K 0.03% 577
2022
Q1 		$5.06M Buy
61,871
+17,630
+40% +$1.37M 0.03% 521
2021
Q4 		$3.87M Buy
44,241
+233
+0.5% +$19.4K 0.03% 531
2021
Q3 		$3.48M Buy
44,008
+1,458
+3% +$120K 0.03% 559
2021
Q2 		$3.58M Sell
42,550
-723
-2% -$59.5K 0.03% 570
2021
Q1 		$3.19M Sell
43,273
-2,995
-6% -$214K 0.03% 638
2020
Q4 		$3.06M Sell
46,268
-2,928
-6% -$163K 0.03% 612
2020
Q3 		$2.22M Sell
49,196
-989
-2% -$47.9K 0.02% 671
2020
Q2 		$2.42M Buy
50,185
+1,070
+2% +$53.6K 0.03% 636
2020
Q1 		$2.22M Hold
49,115
– – 0.03% 568
2019
Q4 		$3.7M Sell
49,115
-364
-0.7% -$27.6K 0.04% 511
2019
Q3 		$3.65M Sell
49,479
-482
-1% -$37.1K 0.04% 488
2019
Q2 		$3.6M Sell
49,961
-983
-2% -$71.9K 0.04% 515
2019
Q1 		$4.95M Sell
50,944
-9
-0% -$840 0.01% 872
2018
Q4 		$4.66M Sell
50,953
-63
-0.1% -$6.77K 0.06% 310
2018
Q3 		$6.32M Buy
+51,016
New +$6.02M 0.06% 276

Other funds holding LIVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MetLife Investment Management's LIVN Position: Q2 2026 in Review

MetLife Investment Management increased its LivaNova (LIVN) stake by 3.4% in Q2 2026, buying an estimated $136K and bringing the position to 58,262 shares worth $4.79M. The position accounts for 0.02% of the portfolio, ranked #661.

MetLife Investment Management first reported a position in LIVN in Q3 2018 and has held it in 31 quarters since. The position peaked at $6.32M in Q3 2018. 303 funds tracked by Wall St. Rank hold LIVN as of Q2 2026.

  • MetLife Investment Management held 58,262 shares of LivaNova worth $4.79M as of Q2 2026.
  • MetLife Investment Management bought 1,924 LivaNova shares in Q2 2026, an estimated $136K.
  • LivaNova made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #661 holding.
  • MetLife Investment Management first reported a position in LivaNova in Q3 2018 and has held it in 31 quarters since.
  • MetLife Investment Management's LivaNova position peaked at $6.32M in Q3 2018.
  • 303 funds tracked by Wall St. Rank held LivaNova as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.